FOLLICULAR LYMPHOMA
Clinical trials for FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients sought for groundbreaking blood cancer drug trial
Disease control Not yet recruitingThis is the first study in people testing a new drug called LY4584180 for adults with certain blood cancers that have come back or stopped responding to previous treatments. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs tha…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for lymphoma patients as major trial tests promising drug
Disease control Not yet recruitingThis study is testing whether a new drug called TQB2825 works better than standard immunotherapy for people with follicular lymphoma that has returned or hasn't responded to previous treatments. The trial will involve 228 adults who have already tried at least two other treatment…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE3 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New shot aims to control blood cancer without hospital stays
Disease control Not yet recruitingThis study is testing a new under-the-skin injection called mosunetuzumab for people with a slow-growing type of blood cancer called follicular lymphoma who haven't had any treatment yet. The goal is to see if this immunotherapy can effectively shrink tumors while being more conv…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New immune cell attack tested for tough blood cancers
Disease control Not yet recruitingThis early-stage study is testing the safety of a new combination treatment for people with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment adds an experimental therapy—'natural killer' (NK) immune cells from a donor—…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for blood cancer patients after other treatments fail
Disease control Not yet recruitingThis study aims to see how well the drug Tazemetostat works for adults with follicular lymphoma, a slow-growing blood cancer, that has come back or stopped responding to at least two prior treatments. Doctors will observe patients receiving Tazemetostat in real-world settings to …
Matched conditions: FOLLICULAR LYMPHOMA
Sponsor: Ipsen • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Chemotherapy-Free triple attack on blood cancer shows promise
Disease control Not yet recruitingThis study is testing a new combination of three targeted drugs (zanubrutinib, obinutuzumab, and lenalidomide) for people with follicular lymphoma who haven't had any previous treatment. The goal is to see if this chemotherapy-free approach can effectively control the cancer whil…
Matched conditions: FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC